Rifaximin: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "rxn" to "reaction") |
Neil.m.young (talk | contribs) (Text replacement - " ==" to "==") |
||
| Line 14: | Line 14: | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===For > 12 yrs old === | ===For > 12 yrs old=== | ||
*Traveler's diarrhea, E. coli-induced: 200 mg PO tid x3 days | *Traveler's diarrhea, E. coli-induced: 200 mg PO tid x3 days | ||
Revision as of 09:09, 9 July 2016
Administration
- Type: Antibiotic
- Dosage Forms: 200, 550
- Routes of Administration: Oral
- Common Trade Names: Xifaxan
Adult Dosing
- Traveler's diarrhea, E. coli-induced: 200 mg PO tid x3 days
- Hepatic encephalopathy: 550 mg PO bid
- IBS, diarrhea-predominant: 550 mg PO tid x14 days
- May repeat dose up to 2x if recurrent dz
Pediatric Dosing
For > 12 yrs old
- Traveler's diarrhea, E. coli-induced: 200 mg PO tid x3 days
Special Populations
Renal Dosing
- No adjustment
Hepatic Dosing
- No adjustment
Contraindications
- Allergy to class/drug
- caution if hepatic impairment (Child-Pugh Class C)
- caution if recent abx-associated colitis
Adverse Reactions
Serious
- superinfection
- C. difficile-assoc. diarrhea
- hypersensitivity reaction
- angioedema
- anaphylaxis
- exfoliative dermatitis
Common
- peripheral edema
- nausea
- dizziness
- fatigue
Comments
See Also
References
<Epocrates, UpToDate>